Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Cancer Diagnostics Market, by region, 2020-2028 (USD Billion)
1.2.2. Cancer Diagnostics Market, by Diagnostic Type, 2020-2028 (USD Billion)
1.2.3. Cancer Diagnostics Market, by Application, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Diagnostics Market Dynamics
3.1. Cancer Diagnostics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of cancer
3.1.1.2. Growing public and private initiatives regarding early diagnosis of cancer
3.1.2. Market Challenges
3.1.2.1. High cost of cancer diagnosis
3.1.2.2. Lack of proper healthcare infrastructure in developing countries
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Growing health consciousness
Chapter 4. Global Cancer Diagnostics Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Cancer Diagnostics Market, by Diagnostic Type
6.1. Market Snapshot
6.2. Global Cancer Diagnostics Market by Diagnostic Type, Performance - Potential Analysis
6.3. Global Cancer Diagnostics Market Estimates & Forecasts by Diagnostic Type 2019-2028 (USD Billion)
6.4. Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Diagnostic Imaging Tests
6.4.2. Biopsy and Cytology Tests
6.4.3. Tumour Biomarkers
6.4.4. Other Diagnostic Types
Chapter 7. Global Cancer Diagnostics Market, by Application
7.1. Market Snapshot
7.2. Global Cancer Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Cancer Diagnostics Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
7.4. Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Breast Cancer
7.4.2. Lung Cancer
7.4.3. Cervical Cancer
7.4.4. Kidney Cancer
7.4.5. Liver Cancer
7.4.6. Pancreatic Cancer
7.4.7. Ovarian Cancer
7.4.8. Other Applications
Chapter 8. Global Cancer Diagnostics Market, Regional Analysis
8.1. Cancer Diagnostics Market, Regional Market Snapshot
8.2. North America Cancer Diagnostics Market
8.2.1. U.S. Cancer Diagnostics Market
8.2.1.1. Diagnostic Type breakdown estimates & forecasts, 2019-2028
8.2.1.2. Application breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Cancer Diagnostics Market
8.3. Europe Cancer Diagnostics Market Snapshot
8.3.1. U.K. Cancer Diagnostics Market
8.3.2. Germany Cancer Diagnostics Market
8.3.3. France Cancer Diagnostics Market
8.3.4. Spain Cancer Diagnostics Market
8.3.5. Italy Cancer Diagnostics Market
8.3.6. Rest of Europe Cancer Diagnostics Market
8.4. Asia-Pacific Cancer Diagnostics Market Snapshot
8.4.1. China Cancer Diagnostics Market
8.4.2. India Cancer Diagnostics Market
8.4.3. Japan Cancer Diagnostics Market
8.4.4. Australia Cancer Diagnostics Market
8.4.5. South Korea Cancer Diagnostics Market
8.4.6. Rest of Asia Pacific Cancer Diagnostics Market
8.5. Latin America Cancer Diagnostics Market Snapshot
8.5.1. Brazil Cancer Diagnostics Market
8.5.2. Mexico Cancer Diagnostics Market
8.6. Rest of The World Cancer Diagnostics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. DICKINSON AND COMPANY
9.2.1.1. KEY INFORMATION
9.2.1.2. OVERVIEW
9.2.1.3. FINANCIAL (SUBJECT TO DATA AVAILABILITY)
9.2.1.4. PRODUCT SUMMARY
9.2.1.5. RECENT DEVELOPMENTS
9.2.2. F. HOFFMANN-LA ROCHE LTD
9.2.3. THERMO FISHER SCIENTIFIC INC.
9.2.4. ABBOTT LABORATORIES INC.
9.2.5. ILLUMINA INC
9.2.6. BIOMERIEUX SA
9.2.7. BIO-RAD LABORATORIES, INC.
9.2.8. ROCHE HOLDINGS AG
9.2.9. DANAHER CORPORATION
9.2.10. HOLOGIC INC.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption